PBS Newshour reports: The refusal to grant protection for Abbott means generic-drug companies can continue selling copies of the medication at a fraction of the price to the developing world.
PBS Newshour reports: The refusal to grant protection for Abbott means generic-drug companies can continue selling copies of the medication at a fraction of the price to the developing world.
Learn more about how you can help build a more equitable system for all